These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6428345)

  • 21. [Beneficial effects of disopyramide on left ventricular outflow obstruction in a case of hypertrophic obstructive cardiomyopathy].
    Terrosu P; Franceschino V; Contini GM; Dore L; Ibba GV
    G Ital Cardiol; 1984 Jan; 14(1):63-6. PubMed ID: 6538527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of life-threatening thiamine deficiency in infants in Israel caused by a defective soy-based formula.
    Fattal-Valevski A; Kesler A; Sela BA; Nitzan-Kaluski D; Rotstein M; Mesterman R; Toledano-Alhadef H; Stolovitch C; Hoffmann C; Globus O; Eshel G
    Pediatrics; 2005 Feb; 115(2):e233-8. PubMed ID: 15687431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Secondary atypical hypertrophy: hypertrophic cardiomyopathy with acquired risk factors (author's transl)].
    Koga Y; Itaya K; Toshima H
    J Cardiogr; 1981 Dec; 11(4):1063-75. PubMed ID: 7201489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid-induced hypertrophic cardiomyopathy following stem cell transplantation in a neonate: a case report.
    Lesnik JJ; Singh GK; Balfour IC; Wall DA
    Bone Marrow Transplant; 2001 May; 27(10):1105-8. PubMed ID: 11438829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy.
    Ruzyłło W; Chojnowska L; Demkow M; Witkowski A; Kuśmierczyk-Droszcz B; Piotrowski W; Rausinska L; Karcz M; Małecka L; Rydlewska-Sadowska W
    Eur Heart J; 2000 May; 21(9):770-7. PubMed ID: 10739733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Possibilities of a differentiated approach to the treatment of patients with idiopathic hypertrophic subaortic stenosis].
    Fedorova IF
    Vestn Akad Med Nauk SSSR; 1984; (2):52-5. PubMed ID: 6538734
    [No Abstract]   [Full Text] [Related]  

  • 27. Impaired response of left ventricular relaxation to exercise-induced adrenergic stimulation in patients with hypertrophic cardiomyopathy.
    Izawa H; Yokota M; Nagata K; Iwase M; Sobue T
    J Am Coll Cardiol; 1996 Dec; 28(7):1738-45. PubMed ID: 8962560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early amelioration of neurologic deficit by lidoflazine after fifteen minutes of cardiopulmonary arrest in dogs.
    Winegar CP; Henderson O; White BC; Jackson RE; O'Hara T; Krause GS; Vigor DN; Kontry R; Wilson W; Shelby-Lane C
    Ann Emerg Med; 1983 Aug; 12(8):471-7. PubMed ID: 6881642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized clinical study of a calcium-entry blocker (lidoflazine) in the treatment of comatose survivors of cardiac arrest.
    Brain Resuscitation Clinical Trial II Study Group
    N Engl J Med; 1991 May; 324(18):1225-31. PubMed ID: 2014035
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A quantitative morphological assessment of the effect of lidoflazine and deferoxamine therapy on global brain ischaemia.
    Kumar K; White BC; Krause GS; Indrieri RJ; Evans AT; Hoehner TJ; Garritano AM; Koestner A
    Neurol Res; 1988 Sep; 10(3):136-40. PubMed ID: 2905775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.
    Meilink-Hoedemaker LJ; Pool J; Muste-Heijns MM
    Acta Med Scand; 1976; 199(1-2):17-23. PubMed ID: 766572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vulnerability of the brain and heart after cardiac arrest.
    Plum F
    N Engl J Med; 1991 May; 324(18):1278-80. PubMed ID: 2014039
    [No Abstract]   [Full Text] [Related]  

  • 34. Hypertrophic cardiomyopathy.
    Bohachick P; Rongaus AM
    Am J Nurs; 1984 Mar; 84(3):320-6. PubMed ID: 6367471
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anti-arrhythmic action of lidoflazine].
    Zini C; Domenici M
    Torace; 1976 Dec; 19(1-4):100-5. PubMed ID: 1052720
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lidoflazine and dysrhythmia (author's transl)].
    Bergouignan J; Lefebvre D; Levol B; Ory J
    Ann Cardiol Angeiol (Paris); 1976; 25(2):155-60. PubMed ID: 1267401
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of lidoflazine and mioflazine against potassium and veratrine induced shape changes in isolated rat cardiac myocytes.
    Ver Donck L; Liu GS; Vandeplassche G; Borgers M
    Basic Res Cardiol; 1987; 82(1):74-81. PubMed ID: 3593184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The ultrastructure of human livers after prolonged lidoflazine therapy.
    Verheyen A; Borgers M; Blaton H; Sowa H
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):224-32. PubMed ID: 1209621
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of lidoflazine (Clinium) as an anti-arrhythmia agent].
    Niederland V; Poór F
    Orv Hetil; 1979 Mar; 120(9):525-7. PubMed ID: 424229
    [No Abstract]   [Full Text] [Related]  

  • 40. Calcium blockers after cardiac arrest: history repeats itself.
    Abramson N
    Am J Emerg Med; 1985 Jan; 3(1):82-3. PubMed ID: 3882097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.